Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion type Assertion NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_head.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion description "[We therefore aimed to study receptor conversion for estrogen receptor alpha (ER?), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in a large group of distant (non-bone) breast cancer metastases by re-staining all primary tumors and metastases with current optimal immunohistochemical and in situ hybridization methods on full sections.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_provenance.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion evidence source_evidence_literature NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_provenance.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion SIO_000772 20863372 NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_provenance.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion wasDerivedFrom befree-20150227 NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_provenance.
- NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_assertion wasGeneratedBy ECO_0000203 NP385111.RAJGmkTViN9uELA0mg4RAKGROff2_Lod9a2AJilC-v_ps130_provenance.